Metabolic disturbances in liver cirrhosis (part 1) - Hepatic osteopathy and malnutrition: Diagnostic aspects and treatment;Metabolische störungen bei leberzirrhose (teil 1): Hepatische osteopathie und malnutrition: Aktueller stand der diagnostik und therapie

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 48, 2009, Pages 2461-2464

  Gundling, F ^a   Seidl, H ^a   Loffler N ^a   Strassen, I ^a   Schepp, W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hepatic osteopathy; Liver cirrhosis; Malnutrition; Metabolic complications

Indexed keywords

CALCIUM; COLECALCIFEROL; PROTEIN; RALOXIFENE; STRONTIUM RANELATE; TESTOSTERONE; ZOLEDRONIC ACID;

DIET SUPPLEMENTATION; HEPATIC OSTEOPATHY; HORMONAL THERAPY; HUMAN; HYPOGONADISM; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MALNUTRITION; METABOLIC DISORDER; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PROGNOSIS; REVIEW;

DIETARY PROTEINS; ENERGY INTAKE; HUMANS; LIVER CIRRHOSIS; MALNUTRITION; OSTEOPOROSIS;

EID: 73349091184     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1243029     Document Type: Review

References (27)

1. Aqel B A., Scolapio J S., Dickson R C., et al. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005 3 1095-1100
2. Bajaj J S., Saeian K, Christensen K M., et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008 103 1707-1715
3. Chang Y W. Indication of treatment for esophageal varices: who and when? Digestive Endoscopy 2006 18 10-15
4. Cirera I, Bauer T M., Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001 34 32-37
5. Durnin J V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974 32 77-97
6. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997 112 463-472
7. Figueiredo F A., Dickson E R., Pasha T M., et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000 6 575-581
8. Ginès A, Escorsell A, Ginès P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993 105 229-236
9. Guglielmi F W., Panella C, Buda A, et al. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the Nutritional Problems in Gastroenterology Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2005 37 681-688
10. Guichelaar M M., Schmoll J, Malinchoc M, et al. Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology 2007 46 1198-1207
11. Gundling F, Schepp W. Ernährung bei Leberzirrhose. Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr 2008 133 846-851
12. Hay J E. Bone disease in cholestatic liver disease. Gastroenterology 1995 108 276-283
13. Kovalak M, Lake J, Mattek N, et al. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc 2007 65 82-88
14. Leslie W D., Bernstein C N., Leboff M S., American Gastroenterological Association Clinical Practice Committee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003 125 941-966
15. Matos C, Porayko M K., Francisco-Ziller N, et al. Nutrition and chronic liver disease. J Clin Gastroenterol 2002 35 391-397
16. Menon K V., Angulo P, Boe G M., et al. Safety and efficacy of estrogen therapy in preventing loss in primary biliary cirrhosis. Am J Gastroenterol 2003 98 889-892
17. Merli M, Nicolini G, Angeloni S, et al. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 2002 18 978-986
18. Moschen A R., Kaser A, Stadlmann S, et al. The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol 2005 43 973-983
19. Norman K, Kirchner H, Lochs H, et al. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006 12 3380-2285
20. Ormarsdóttir S, Ljunggren O, Mallmin H, et al. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 1999 31 84-90
21. Petrides A S. Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis. Z Gastroenterol 1999 Suppl 1 15-21
22. Pirlich M, Schutz T, Spachos T, et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000 32 1208-1215
23. Plauth M, Cabre E, Riggio O, et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006 25 285-294
24. Schiefke I, Fach A, Wiedmann M, et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005 11 1843-1847
25. Schenk P, Schöniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003 125 1042-1052
26. Temmel A F., Pabinger S, Quint C, Munda P, Ferenci P, Hummel T. Dysfunction of the liver affects the sense of smell. Wien Klin Wochenschr 2005 117 26-30
27. WHO. Report of a WHO Expert Committee. Physical status: the use and interpretation of anthropometry. Genf WHO 1995 854-854